Cosmos Health, Inc. is a pharmaceutical company, which engages in the importation, exportation, distribution, and sale of pharmaceutical products. The firm owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. The company also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. The company also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Follow-Up Questions
¿Cuál es el ratio P/E de Cosmos Health Inc (COSM)?
El ratio P/E de Cosmos Health Inc es N/A
¿Quién es el CEO de Cosmos Health Inc?
Mr. Grigorios Siokas es el Chairman of the Board de Cosmos Health Inc, se unió a la empresa desde 2016.
¿Qué tal es el rendimiento del precio de la acción COSM?
El precio actual de COSM es de 0.945, ha increased un 1.4% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Cosmos Health Inc?
Cosmos Health Inc pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de Cosmos Health Inc?
La capitalización bursátil actual de Cosmos Health Inc es $28.5
¿Es Cosmos Health Inc una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 3 analistas han realizado calificaciones de análisis para Cosmos Health Inc, incluyendo 2 fuerte compra, 4 compra, 1 mantener, 0 venta, y 2 fuerte venta
